Group 1 - The domestic tire market in China is continuously expanding, with a projected tire production of 1.187 billion units in 2024, representing a year-on-year growth of 1.46%, marking a historical high [11][24] - The automotive tire market for original equipment manufacturers (OEMs) in China is expected to reach a scale of 77.57 billion yuan in 2024, driven by the growth in automotive production and sales [16][17] - The aftermarket for automotive tires in China is projected to reach 109.876 billion yuan in 2024, supported by the increasing vehicle ownership, which is estimated to be 353 million vehicles by the end of 2024 [17][22] Group 2 - The global off-the-road (OTR) tire market, which is a significant segment of the tire industry, had a market size of 26.6 billion USD in 2022 and is expected to grow to 40 billion USD by 2028, with a compound annual growth rate (CAGR) of 7.5% [20][23] - The demand for OTR tires is driven by increased spending on mining exploration and construction investments, indicating a robust growth trajectory in this niche market [20][21] Group 3 - The chemical new materials sector in the North Exchange has shown a weekly increase of 4.24%, with the metal new materials segment performing exceptionally well, achieving a weekly growth of 35.71% [30][34] - Notable individual stocks in the chemical new materials sector include Tianli Composite, which surged by 117.21%, and other companies like Tiangong Co. and Kolon New Materials, which also experienced significant gains [34][37] Group 4 - The company Taike Ying focuses on the global mining and construction tire market, specializing in the design, research and development, sales, and service of mining and construction tires [24] - Taike Ying has established a strong customer base, including renowned mining companies and equipment manufacturers, and has been recognized by major international mining firms [24]

食品饮料 2025 年 12 月 14 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -19% -10% 0% 10% 19% 29% 2024-12 2025-04 2025-08 食品饮料 沪深300 相关研究报告 《白酒短期批价扰动，西麦新品值得 关注—行业周报》-2025.12.7 《茅台韧性凸显，建议长期配置布局 —行业周报》-2025.11.30 《乳制品供需拐点可期，三大机会驱 动行业成长—行业周报》-2025.11.23 中央经济工作会议积极定调，飞天批价或止跌触底 ——行业周报 张宇光（分析师） 张思敏（分析师） zhangyuguang@kysec.cn 证书编号：S0790520030003 zhangsimin@kysec.cn 证书编号：S0790525080001 核心观点：政策红利提振消费情绪，贵州茅台加码控价 12 月 8 日-12 月 12 日，食品饮料指数跌幅为 1.6%，一级子行业排名第 21，跑输 沪深 300 约 1.5pct，子行业中其他食品（+0.0%）、乳品（-1.1%）、啤酒（-1.3%） 表现相对领先。本周中央经济工作会议将"坚持内需主导，建设强大 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The pork price is expected to rise due to limited supply before the New Year, with the average price of live pigs at 11.43 yuan/kg as of December 12, 2025, showing a week-on-week increase of 0.22 yuan/kg but a year-on-year decrease of 4.33% [12][13] - The beef market is showing signs of a bullish cycle, with the wholesale price of beef at 66.24 yuan/kg, up 10.22% year-on-year, and calf prices at 32.23 yuan/kg, up 33.68% year-on-year [24] - The pig farming sector is facing accelerated losses, leading to a potential increase in the pace of pig culling, while the pet sector is benefiting from domestic brand growth due to consumption upgrades and tariff barriers [27][31] Summary by Sections Weekly Observation - The cold wave is boosting pork consumption as the pickled meat season approaches, with limited supply expected before the New Year [12] - The average weight of pigs slaughtered is 129.63 kg, with a decrease in the proportion of smallholder sales [12][13] Weekly Market Performance (Dec 8-12) - The agricultural sector outperformed the market by 0.26 percentage points, with the Shanghai Composite Index down 0.34% and the agricultural index down 0.08% [32] - Leading stocks included *ST Zhengbang (+19.40%), Biological Shares (+17.16%), and Luoniushan (+13.73%) [32][39] Price Tracking (Dec 8-12) - The average price of live pigs was 11.48 yuan/kg, up 2.50% week-on-week, while the price of piglets was 19.04 yuan/kg, down 1.14% [41] - The average price of beef was 66.13 yuan/kg, showing a slight decrease [48] Key News (Dec 8-12) - China's soybean imports for the first 11 months of 2025 reached 104 million tons, an increase of 6.9% year-on-year, with a price drop of 10.7% [40]

Investment Rating - The investment rating for the automotive industry is "Positive" (maintained) [1] Core Insights - The automotive industry is focusing on domestic demand and optimizing the "Two New" policies, which are expected to enhance the implementation of vehicle replacement programs [5][13] - The commercial vehicle market has shown significant growth, with heavy truck sales exceeding one million units and a 1.2 times increase in new energy vehicle exports [18] - The passenger car market is experiencing unexpected demand in the high-end luxury segment, with companies like Jianghuai Automobile and Seres recommended for investment [7] Industry News - The Central Economic Work Conference has prioritized domestic demand and the optimization of the "Two New" policies for 2026 [5][13] - Zhongtong Bus held a supply chain strategic partnership conference, emphasizing quality and innovation in their product offerings [14] - Ankai Bus has exported 1,800 units to Saudi Arabia in 2025, marking a significant milestone in Sino-Saudi transportation cooperation [15] - The China Automobile Association has called for compliance with pricing guidelines to prevent irrational competition in the automotive industry [16] Market Performance - The automotive sector outperformed the market with a weekly increase of 0.09%, ranking 9th among A-share industries [6][31] - The passenger vehicle index rose by 0.24%, led by Great Wall Motors and Geely [6][36] - The commercial vehicle index increased by 0.21%, with CIMC Vehicles and Zhongtong Bus leading the gains [6][37] - The automotive parts index saw a slight decline of 0.11%, with Huamao Technology and Yueling Co. leading the gains [6][38] Investment Recommendations - For passenger vehicles, the high-end luxury market is expected to grow, with recommendations for Jianghuai Automobile and Seres, while Geely is identified as a beneficiary [7] - In the automotive parts sector, companies like Desay SV, Zhejiang Xiantong, and Meili Technology are recommended due to their growth potential [7]

计算机 2025 年 12 月 14 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -24% -12% 0% 12% 24% 36% 2024-12 2025-04 2025-08 计算机 沪深300 相关研究报告 《商业航天，大国重器—行业深度报 告》-2025.12.11 《重视商业航天产业大趋势—行业周 报》-2025.12.7 《商业航天有望进入高速发展期—行 业周报》-2025.11.30 周观点：商业航天产业催化密集 ——行业周报 | 陈宝健（分析师） | 刘逍遥（分析师） | | --- | --- | | chenbaojian@kysec.cn | liuxiaoyao@kysec.cn | | 证书编号：S0790520080001 | 证书编号：S0790520090001 | liuxiaoyao@kysec.cn 证书编号：S0790520090001 市场回顾：本周（2025.12.8-2025.12.12），沪深 300 指数下跌 0.08%，计算 机指数下跌 1.14%。 周观点：AI 产业持续繁荣 （1）SpaceX 或将开启史上最大规模 IPO，目标估值约 1.5 ...

Investment Rating - The investment rating for the pharmaceutical and biotechnology industry is "Positive" (maintained) [1] Core Insights - The 2025 National Medical Insurance Negotiation results were announced, with 114 new drugs added to the medical insurance directory, achieving an overall success rate of 88%, the highest in nearly seven years, with a maximum price reduction of 94 [4][19] - The newly added drugs include monoclonal antibodies, bispecific antibodies, ADCs, siRNA, and small molecules, indicating a strong focus on innovative therapies [19][32] - The commercial insurance directory has added 19 innovative drugs, which, while not reimbursed by medical insurance, receive support for innovative drug applications, enhancing patient access and benefiting the innovative drug industry [5][24] Summary by Sections 1. National Medical Insurance Negotiation Results - The 2025 medical insurance directory added 114 new drugs, with a success rate of 88% and a maximum price reduction of 94% [4][13] - The total number of drugs in the national medical insurance directory reached 3,253, including 1,857 Western medicines and 1,396 traditional Chinese medicines [16][17] - The directory reflects a significant increase in the inclusion of innovative drugs, with 50 of the new additions classified as category 1 innovative drugs [19][21] 2. Commercial Insurance Directory - The commercial insurance directory added 19 innovative drugs, highlighting their clinical value and innovation [24][28] - The directory includes treatments for diseases such as Alzheimer's, rare diseases in children, and other critical conditions, showcasing a focus on addressing unmet medical needs [24][28] - The support for innovative drugs in the commercial insurance directory aims to fill gaps in patient coverage and enhance the overall healthcare system [25][28] 3. Market Performance - In the second week of December, the pharmaceutical and biotechnology sector declined by 1.04%, underperforming the CSI 300 index by 0.96 percentage points [6][34] - The medical research outsourcing sector showed the highest increase, up by 3.69%, while offline pharmacy and medical circulation sectors experienced the largest declines [6][36] 4. Recommended Companies - The report continues to favor innovative drugs and their supply chain, recommending companies such as Sanofi, Innovent Biologics, and others for investment [7][32]

2025 年 12 月 14 日 金融工程研究团队 魏建榕（首席分析师） 证书编号：S0790519120001 苏俊豪（分析师） 证书编号：S0790522020001 胡亮勇（分析师） 证书编号：S0790522030001 王志豪（分析师） 证书编号：S0790522070003 盛少成（分析师） 证书编号：S0790523060003 蒋 韬（分析师） 证书编号：S0790525070001 相关研究报告 《基于港交所 CCASS 数据的港股投 资策略》-20250914 《国庆前后的港股市场资金流变化》 -2024.10.18 《公募港股投资变化及港股通优选组 合构建》-2024.7.15 《港股优选：技术面、资金面、基本 面》-2022.3.22 《对近期北向持续撤离，南下持续抄 底的几点思考》-2022.3.15 傅开波（分析师） 证书编号：S0790520090003 高 鹏（分析师） 证书编号：S0790520090002 基于杠反 ETF 份额变化的港股择时策略 ——开源量化评论（115） 魏建榕（分析师） 傅开波（分析师） weijianrong@kysec.cn 证书编号：S07905 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The non-bank financial index increased by 0.81%, outperforming the CSI 300 index which decreased by 0.08%. The brokerage and insurance sectors continue to show good trends, with valuations at low levels and relatively stagnant performance throughout the year. The Federal Reserve's interest rate cuts are beneficial for the equity market, directly favoring the profitability of securities firms' overseas businesses due to lower liability costs and asset expansion [4][5] - The average daily trading volume of stock funds reached 2.39 trillion, a 15.1% increase month-on-month, indicating a recovery in trading activity. The cumulative average daily trading volume for the year is 2.05 trillion, a 69.5% year-on-year increase [5] - The China Securities Regulatory Commission's recent positive stance signals a potential "policy easing period" for the industry, which may lead to an increase in leverage limits and support for the profitability of the securities industry. The report recommends focusing on strategic opportunities in undervalued leading companies in the brokerage and insurance sectors [5][6] Summary by Sections Brokerage Sector - The Federal Reserve's interest rate cuts are favorable for the overseas business of brokerages, and new regulations are set to standardize fund sales practices. The report highlights three main lines of recommended stocks: Huatai Securities, Guotai Junan, and CICC for their advantages in overseas and institutional business; GF Securities and Dongfang Securities for their wealth management strengths; and Guosen Securities for its retail advantages [5][6][7] Insurance Sector - The liability side is expected to achieve a "good start," with the transformation of dividend insurance continuing to progress. The demand for "savings" from residents is likely to persist, and the insurance distribution channel is expected to maintain high growth. On the asset side, stable long-term interest rates and a favorable equity market are expected to boost investment returns in the medium to long term [6][7]

Investment Rating - The investment rating for the retail industry is "Positive" (maintained) [1] Core Insights - The Ministry of Commerce has set a positive tone for the retail industry, emphasizing the importance of quality and service-driven transformation. Retailers with strong supply chain advantages and the ability to adapt are expected to benefit [25][27] - Yonghui Supermarket is undergoing a significant transformation focused on product centralization, with 222 stores modified by the end of September 2025. The company has seen a recovery in same-store sales and is enhancing its product quality and differentiation [27][29] Industry Overview - The retail industry index closed at 2305.32 points, down 0.21% for the week, outperforming the Shanghai Composite Index, which fell 0.34% [5][14] - The supermarket sector showed the highest increase among retail sub-sectors, with a weekly rise of 10.73% [17][20] Investment Recommendations - Focus on high-quality companies in sectors benefiting from emotional consumption themes, including: - **Gold and Jewelry**: Recommend brands like Chow Tai Fook and Chow Hong Kee, which are expected to benefit from differentiated product offerings [6][29] - **Offline Retail**: Highlight companies like Yonghui Supermarket and Ai Ying Shi, which are adapting to market changes [6][29] - **Cosmetics**: Recommend domestic brands that emphasize emotional value and innovative safe ingredients, such as Maogeping and Proya [6][29] - **Medical Aesthetics**: Focus on differentiated product manufacturers and expanding medical chains, recommending companies like Aimeike and Kedi-B [6][29] Company-Specific Insights - **Yonghui Supermarket**: The company reported a revenue of 424.34 billion yuan for the first three quarters of 2025, down 22.2% year-on-year, with a net loss of 7.10 billion yuan. The company is in a transformation phase aimed at quality retail [31][43] - **Chow Tai Fook**: The company achieved a revenue of 389.86 billion HKD for FY2026H1, down 1.1%, with a net profit of 25.34 billion HKD, up 0.1%. The company is optimizing its product structure and store quality [36][38] - **Chow Hong Kee**: The company reported a revenue of 62.37 billion yuan for the first three quarters of 2025, up 28.4%, with a net profit of 3.17 billion yuan, up 0.3%. The company is expanding its franchise model and enhancing product differentiation [39][40]

通信 2025 年 12 月 14 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -24% 0% 24% 48% 72% 96% 2024-12 2025-04 2025-08 通信 沪深300 相关研究报告 《国内 AIDC 需求或加速回暖—行业 点评报告》-2025.12.9 《"H200 芯片或放开"下的投资机会 梳理—行业点评报告》-2025.12.9 《"AI+卫星"的共振—行业周报》- 2025.12.7 GPT5.2 发布， "AI+卫星"为核心主线 ——行业周报 | 蒋颖（分析师） | 陈光毅（联系人） | 雷星宇（联系人） | | --- | --- | --- | | jiangying@kysec.cn | chenguangyi@kysec.cn | leixingyu@kysec.cn | | 证书编号：S0790523120003 | 证书编号：S0790124020006 | 证书编号：S0790124040002 | OpenAI 发布最新模型 GPT-5.2，赶超人类专家 12 月 11 日，GPT5.2 在 ChatGPT 上线并推出 Instant、Thinki ...